Critical evaluation of the biological role of IgM in cerebrospinal fluid in inflammatory and other diseases of the nervous system

Folia Microbiologica

Volumn 51, Issue 5, 2006, Pages 485-491

  Svatonova J ^a,b  

^a NA HOMOLCE HOSPITAL   (Czech Republic)

^b RHG City Hospital   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN M;

ARTICLE; BLOOD; CEREBROSPINAL FLUID; CHEMISTRY; CYTOLOGY; FEMALE; HUMAN; IMMUNOLOGY; INFLAMMATION; MALE; NEUROLOGIC DISEASE; PREDICTION AND FORECASTING; PROTEIN CEREBROSPINAL FLUID LEVEL; STATISTICAL MODEL;

BIOLOGICAL MARKERS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN M; INFLAMMATION; LINEAR MODELS; MALE; NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS;

EID: 33751342531     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931596     Document Type: Article

References (40)

1. ADAM P.: Cytology of Cerebrospinal Fluid, pp. 1-52. Stapro-Publishing, Prague 1995.
2. ADAM P., NEKOLA P., HAVRDOVÁ E.: Importance of evaluation of CSF-IgM for clinical practice. Klin.Biochem.Metab. 5, 40-44 (1997a).
3. ADAM P., NEKOLA P., HAVRDOVÁ E.: Evaluation of C3 complement in CSF. Klin.Biochem.Metab. 5, 33-36 (1997b).
4. ADAM P., NEKOLA P., HAVRDOVÁ E.: Monitoring of orosomucoid levels in cerebrospinal fluid in comparison with CSF cytological findings. Klin.Biochem.Metab. 5, 47-50 (1997c).
5. ADAM P., CHENÍČKOVÁ M., NEKOLA P.: The importance of monitoring a microglobulin levels in cerebrospinal fluid. Lab.Diag. 2, 100-102 (1997d).
6. ADAM P., NEKOLA P., HAVRDOVÁ E.: Evaluation of CSF apolipoprotein A-I concentrations - a comparison with CSF cytological findings. Klin.Biochem.Metab. 5, 8-12 (1997e).
7. ADAM P., NEKOLA P., HAVRDOVÁ E., PREININGEROVÁ J., TYL D., CHENÍČKOVÁ M.: Evaluation of C4 complement in cerebrospinal fluid in inflammatory and demyelinating diseases of CNS. Klin.Biochem.Metab. 5, 36-40 (1997f).
8. ADAM P., TÁBORSKÝ L., SOBEK O., HILDEBRAND T., KELBICH P., PRŮCHA M., HYÁNEK J.: Cerebrospinal fluid. Adv.Clin.Chem. 36, 1-62 (2001).
9. ADAM P., SOBEK O., TÁBORSKÝ L., HILDEBRAND T., PRŮCHA M., HYÁNEK J., ŽÁČEK P., VESELÁ B.: Complete proteinogram of cerebrospinal fluid and its contribution to the diagnostics of inflammatory and autoimmune diseases of the central nervous system. 1st Fac.Med.Charles University Quart.J. 104, 1-12 (2003a).
10. 1-glycoprotein) levels in MS patients subgroups. Clin.Chim.Acta 334, 107-110 (2003b).
11. BEDNÁŘOVÁ J., ŠTOURAČ P.: Intrathecal synthesis of specific anti-Borrelia IgG antibodies and its role in diagnostics of neuroborreliosis. Klin.Biochem.Metab. 8, 219-223 (2000).
12. BEDNÁŘOVÁ J., ŠTOURAČ P., ADAM P.: The diagnostic relevance of immunological variables in neuroborreliosis and multiple sclerosis. Acta Neurol.Scand. 112, 97-102 (2005).
13. BLENNOW K., WALLIN A., DAVIDSSON P., FREDMAN P., GOTTFRIES C.G., SVENNERHOLM L.: Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type. Alzheimer Dis.Assoc.Disord. 4, 79-86 (1990).
14. BOEER A., SCHIPPER H.I., PRANGE H.W.: Local IgM production in meningoradiculitis Banwarth and neurosyphilis. J.Neuroimmunol. 20, 315-316 (1988).
15. CHENÍČKOVÁ M., ADAM P., NEKOLA P.: Evaluation of CSF CRP in purulent meningitis. Klin.Biochem.Metab. 5, 27-30 (1997).
16. CHIODI F., SUNDQVIST V.A., NORBY E.: IgM antibodies in cerebrospinal fluid and serum in subacute sclerosing panencephalitis. J.Med. Virol. 18, 149-158 (1986).
17. CHIODI F., SUNDQVIST V.A., LINK H., NORBY E.: Viral IgM antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and controls. Acta Neurol.Scand. 75, 201-208 (1987).
18. DUNIEWICZ M., ADAM P.: Neuro-Infective Diseases. Maxdorf-Jesenius, Prague 1999.
19. ERNERUDH J., OLSSON T., LINDSTROM F., SKOGH T.: Cerebrospinal fluid immunoglobulins abnormalities in systemic lupus erythematosus. J.Neurol.Neurosurg.Psychiat. 48, 807-813 (1985).
20. FELGENHAUER K., SCHADLICH H.J.: The compartmental IgM and IgA response within the central nervous system. J.Neurol.Sci. 77, 125-135 (1987).
21. FORSBERG P., FRYDEN A., LINK H.: Immunoglobulin abnormalities in the cerebrospinal fluid during bacterial meningitis. J.Neuroimmunol. 12, 299-310 (1986).
22. LODIN Z.: Inflammatory and autoimmune diseases of the nervous system. Possibilities of laboratory diagnostic methods in cerebrospinal fluid. Folia Microbiol. 48, 839-847 (2003).
23. PREININGEROVÁ J., ADAM P., NEKOLA P., TYL D., TAUBEROVA A.: Levels of CSF proteins (AAT) in hematological malignancies in the CNS. Klin.Biochem.Metab. 5, 30-33 (1997).
24. REIBER H.: The discrimination between different blood-CSF-barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profils of cerebrospinal fluid. J.Neurol. 89, 224-227 (1980).
25. REIBER H.: Cerebrospinal fluid analysis. Lab.Med. 19, 444-462 (1995).
26. REIBER H.: Cerebrospinal fluid analysis, pp. 38-46 in E.J. Thompson, M. Trojano, P. Livrea (Eds): CSF Analysis in Multiple Sclerosis. Springer-Verlag, Milano 1996.
27. REIBER H., THOMPSON E.J., GRIMSLEY G., BERNARDI G., ADAM P., MONTEIRO DE ALMEIDA S., FREDMAN P., KEIR G., LAMMERS L., LIBLAU R., MENNA-BARRETO M., SÁ M.J., SERES E., SINDIC C.J.M., TEELKEN A., TRENDELENBURG C., TROJANO M., VAN ANTWERPEN M., VERBEEK M.M.: Quality assurance for cerebrospinal fluid analysis: international consensus by an interner-based group discussion. Clin.Chem.Lab.Med. 41, 331-337 (2003).
28. SOBEK O., ADAM P.: Letter to the editors, on S. Seyfert, V. Kunzmann, N. Schwertfeger, H.C. Koch, A. Faulstich: Determinants of lumbar CSF protein concentration. J.Neurol. 250, 371-372 (2003).
29. SOBEK O., ADAM P., ZEMAN D., KELBICH P., TAUBEROVÁ A., TYL D.: Cerebrospinal fluid parameters in patients with neuroborreliosis. Klin.Biochem.Metab. 6, 229-234 (1998).
30. SOBEK O., ADAM P., TÁBORSKÝ L., ZEMAN D., KELBICH P., HILDEBRAND T.: Protein fractions and other cerebrospinal fluid parameters in patients with multiple sclerosis. Klin.Biochem.Metab. 8, 209-212 (2000).
31. SOBEK O., ADAM P., TÁBORSKÝ L., PRŮCHA M., VESELÁ B.: Acute and chronical forms of neuroborreliosis - cerebrospinal fluid differential diagnostics. Klin.Biochem.Metab. 10, 43-50 (2002).
32. ŠTOURAČ P.: Oligoclonal synthesis of IgG in auto-immune neurological paraneoplastic syndromes. Klin.Biochem.Metab. 8, 224-228 (2000).
33. ŠTOURAČ P., BEDNÁŘOVÁ J.: Intrathecal, antiviral and oligoclonal synthesis of IgG in multiple sclerosis and its role in differential diagnostics of neurological disease. Klin.Biochem.Metab. 8, 204-208 (2000).
34. ŠTOURAČ P., BEDNÁŘOVÁ J.: Diagnostic exclusiveness of cerebrospinal fluid analysis - case report. Klin.Biochem.Metab. 11, 125-126 (2003).
35. ŠTOURAČ P., KADAŇKA Z., PALYZA V.: Paraneoplastic neurological syndromes - patients' cohort profile in the Czech Republic. Acta Neurol.Scand. 104, 72-77 (2001).
36. TÁBORSKÝ L., ADAM P., SOBEK O., DOSTÁL M., DVOŘÁROVÁ J., DUBSKÁ L.: Levels of apolipoprotein A-II in cerebrospinal fluid in patients with neuroborreliosis are associated with lipophagocytosis. Folia Microbiol. 48, 849-850 (2003).
37. VRETHEM M., OHMAN S., VON SCHENK H.: Comparison of concentration of orosomucoid in serum and cerebrospinal fluid in different neurological diseases. Acta Neurol.Scand. 75, 328-331 (1987).
38. WEITBRECHT W.U.: Mononuclear phagocytes in the cerebrospinal fluid - clinical significance and factors of activation. Fortschr.Med. 102, 903-905 (1984).
39. ZEMAN D., ADAM P., KALISTOVÁ H., SOBEK O., KELBICH P., ANDĚL J., ANDĚL M.: Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients. Acta Neurol.Scand. 101, 89-94 (2000).
40. ZEMAN D., ADAM P., KALISTOVÁ H., SOBEK O., KELBICH P., ANDĚL J., ANDĚL M.: Cerebrospinal fluid cytological findings in multiple sclerosis: a comparison between patient subgroups. Acta Cytol. 45, 51-59 (2001).